2024-25 Guide to Medications for the Treatment of Diabetes Mellitus
By (Author) John R. White
Edited by Joshua J. Nuemiller
American Diabetes Association
American Diabetes Association
16th October 2024
United States
General
Non Fiction
Endocrinology
Medical study and revision guides and reference material
Pharmacology
Clinical and internal medicine
Coping with / advice about diabetes
Paperback
644
Width 152mm, Height 228mm, Spine 35mm
The 2024-25 Guide to Medications for the Treatment of Diabetes Mellitus is a complete and newly revised reference for every physician, clinician, and educator treating people with diabetes. Compiled and edited by a team of noted pharmacology experts specializing in diabetes care, this guide addresses all aspects of diabetes drug classes including insulins, biguanides, thiazolidinediones, sulfonylureas, glinides, SGLT2 inhibitors, -glucosidase inhibitors, DPP-4 inhibitors, GLP-1 RAs, pramlintide, bile acid sequestrants, and dopamine-2 RAs. Each discussion reflects the latest guidance of the American Diabetes Association's Standards of Care in Diabetes. This guide also features chapters on medication management of comorbidities such as:
Neuropathy
Chronic Kidney Disease
Retinopathy
Hypoglycemia
Obesity
Depression
JOHN R. WHITE, JR., PA-C, PHARMD, is Chair and the R. Keith Campbell Distinguished Professor in Diabetes Care of the Department of Pharmacotherapy at Washington State University College of Pharmacy. Dr. White is the author of three books, more than 30 book chapters, and over 150 manuscripts on diabetes medications. He is currently Associate Editor of Clinical Diabetes.